Histopathological Effects of Mercury in Skin-Lightening Cream

Journal of Environmental Pathology, Toxicology and Oncology

Volumn 22, Issue 4, 2003, Pages 287-299

  Al Saleh, Iman ^a   Khogali, Fathia ^b   Al Amodi, Mona ^b   El Doush, Inaam ^a   Shinwari, Neptune ^a   Al Baradei, Raid ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Histopathological effects; Mercury; Skin lightening creams

Indexed keywords

BLEACHING AGENT; MERCURY;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BRAIN INJURY; BRAIN TISSUE; CONTROLLED STUDY; CREAM; DISEASE SEVERITY; FEMALE; HISTOPATHOLOGY; KIDNEY INJURY; KIDNEY PARENCHYMA; LIVER; LIVER INJURY; MERCURY BLOOD LEVEL; NONHUMAN; PRIORITY JOURNAL; SKIN TOXICITY; SPECIES COMPARISON; TISSUE SECTION; TRACE METAL BLOOD LEVEL;

ADMINISTRATION, CUTANEOUS; ADSORPTION; ANIMALS; BRAIN; COSMETICS; DERMATOLOGIC AGENTS; FEMALE; KIDNEY; LIVER; MERCURY; MICE; SKIN PIGMENTATION; TISSUE DISTRIBUTION;

ANIMALIA;

EID: 0345256301     PISSN: 07318898     EISSN: None     Source Type: Journal    
DOI: 10.1615/JEnvPathToxOncol.v22.i4.30     Document Type: Article

References (81)

1. Cole HN, Schreiber N, Sollman T. Mercurial ointment in the treatment of syphilis. Arch Dermatol 1930; 21:372-393.
2. Turk JL, Baker H. Nephrotic syndrome due to ammoniated mercury. Br J Dermatol 1968; 80:623-624.
3. Marzulli FN, Brown WC. Potential systemic hazards of topically applied mercurials. J Soc Cosmet Chem 1972; 23:875-886.
4. Mahe A, Blanc L, Halna JM, Keita S, Sanogo T, Bobin P. [An epidemiologic survey on the cosemetic use of bleaching agents by the women of Bamako (Mali)]. Ann Dermatol Venereol 1993; 120:870-873.
5. Koriakov VV, Goldfarb LUS. [Acute gray mercury ointment poisoning]. Anesteziol Reanimatol 1995; 3:59-60.
6. Balluz LS, Philen RM, Sewell CM, Voorhees RE, Falter KH, Paschal D. Mercury toxicity associated with a beauty lotion, New Mexico. Int J Epidemiol 1997; 26:1131-1132.
7. Garza-Ocanas L, Torres-Alanis O, Pineyro-Lopez A. Urinary mercury in twelve cases of cutaneous mercurous chloride (calomel) exposure: Effect of sodium 2,3-dimercaptopropane-1-sulfonate (DMPS) therapy. J Toxicol Clin Toxicol 1979; 35:653-655.
8. Jovanovic S, Maisner V, Horras-hu G, Garbis T, Schwenk M. Poisoning of a family by a mercury-containing ointment. Gesundheitswesen 1997; 59:405-408.
9. Weldon MM, Smolinski MS, Maroufi A, Hasty BW, Gilliss DL, Boulanger LL, Balluz LS, Dutton RJ. Mercury poisoning associated with a Mexican beauty cream. West J Med 2000; 173:15-18.
10. McRill C, Boyer LV, Flood TJ, Ortega L. Mercury toxicity due to use of a cosmetic cream. J Occup Environ Med 2000; 42:4-7.
11. Barr RD, Woodger BM, Rees PH. Levels of mercury in urine correlate with the use of skin lightening creams. Am J Clin Pathol 1973; 59:36-40.
12. Bourgeois M, Dooms-Goossens A, Knockard D, Sprengers D, Van Boven M, Van Tittelboom M. Mercury intoxication after topical application of metallic mercury ointment. Dermatologica 1986; 172:48-51.
13. Berlin M. Mercury. In: Friberg L, Nordberg GF, Vouk VL, eds. Handbook on the Toxicology of Metals. Amsterdam: Elsevier/North-Holland, 1979.
14. Silverberg DS, McCall JT, Hunt JC. Nephrotic syndrome with the use of ammoniated mercury. Arch Intern Med 1967; 120:581-586.
15. Kibuhamusohe JW, Davies DR, Hutt MSR. Membranous nephropathy due to skin lightening cream. Br Med J 1974; 2:646-647.
16. Lyons TJ, Christu CN, Larsen FS. Ammoniated mercury ointment and the nephrotic syndrome. Minn Med 1975; 58:383-384.
17. Jeddeloh RJ, Lake KD, Brown DC. Ammoniated mercury membranous nephropathy. Minn Med 1985; 68:591-592.
18. Oliveira, DBG, Foster G, Savill J, Syme PD, Taylor A. Memberanous nephropathy caused by mercury-containing skin lightening cream. Postgrad Med J 1987; 63:303-304.
19. Neubert D, Stahlmann R, Chahoud I, Bochert G. Some aspects of prenatal toxicology. TIPS 1985:21-26.
20. Kavlock RJ, Gray JA. Morphometric, biochemical, and physiological assessment of perinatally induced renal dysfunction. J Toxicol Environ Health 1983; 11:1-13.
21. Kavlock RJ, Gray LE Jr. Postnatal evolution of morphological and functional effects of prenatal exposure to nitrofen in the Long-Evans rat. J Toxicol Environ Health 1983; 11:679-690.
22. Lauwerys R, Bonnier CH, Evrard PH, Gennart PH, Bernard A. Prenatal and early postnatal intoxication by inorganic mercury resulting from the maternal use of mercury containing soap. Hum Toxicol 1987; 6:253-256.
23. Boadi WY, Urbach J, Brandes JM, Yannai S. In vitro exposure to mercury and cadmium alters term human placental membrane fluidity. Toxicol Appl Pharmacol 1992; 116:17-23.
24. Bakri F, Damluji S, Amin-Zaki L, Murtadha M, Khalidi A, Al-Rawi NY, Tikriti S, Dahahr HJ, Clarkson TW, Smith JC, Doherty RA. Methyl-mercury poisoning in Iraq. Science 1973; 181:203-241.
25. Ngim CH, Foo SC, Boey KW, Jeyaratnam J. Chronic neurobehavioural effects of elemental mercury in dentists. Br J Ind Med 1992; 49:782-790.
26. Warfvinge K. Mercury distribution in the mouse brain after mercury vapour exposure. Int J Exp Pathol 1995; 76:29-35.
27. Cox C, Clarkson TW, Marsh DO, Amin-Zaki L, Tikriti S, Myers GG. Dose-response analysis of infants prenatally exposed to methylmercury: an application of a single compartment model to single strand hair analysis. Environ Res 1989; 49:318-332.
28. Myers GJ, Davidson PW, Shamlaye CF. A review of methylmercury and child development. Neurotoxicology 1998; 19:313-328.
29. Sørensen N, Murata K, Budtz-Jørgensen E, Weihe P, Grandjean P. Prenatal methylmercury exposure as a cardiovascular risk factor at seven years of age. Epidemiology 1999; 10:370-375.
30. Murta K, Weihe P, Renzoni A, Debes F, Vasconcelos R, Zino F, Araki S, Jorgensen PJ, White RF, Grandjean P. Delayed evoked potentials in children exposed to methylmercury from seafood. Neurotoxicol Teratol 1999; 21:343-348.
31. Szasz A, Barna B, Szupera Z, De Visscher G, Galbacs Z, Kirsch-Volders M, Szente M. Chronic low-dose maternal exposure to methylmercury enhances epileptogenicity in developing rats. Int J Dev Neurosci 1999; 17:733-742.
32. Grandjean P, Budtz-Jorgensen E, White RF, Jorgensen PJ, Weihe P, Debes F, Keiding N. Methylmercury exposure biomarkers as indicators of neurotoxicity in children aged 7 years. Am J Epidemiol 1999; 150:301-305.
33. Neal PA, Jones PR. Chronic mercurialism in the hatter's furcutting industry. J Am Med Wom Assoc 1938; 110:337-343.
34. Hunter D, Bomford RR, Russel DS. Poisoning by methylmercury compounds. QJM 1940; 9:193-213.
35. McAlpine D, Araki S. Minamata disease: an unusual neurological disorder caused by contaminated fish. Lancet 1958; 2:629-631.
36. Kantarjiam AD. A syndrome resembling ALS following chronic mercurialism. Neurology 1961; 11:639-644.
37. Goldstein N, McCall JT, Dyck PJ. Metal neuropathy. In: Dyck PJ, Thomas PK, Lambert EH, eds. Peripheral neuropathy. Vol. 2. Philadephia: WB Saunders, 1975:1249-1251.
38. Vroom FQ, Greer M. Mercuryvapour intoxication. Brain 1972; 95:305-318.
39. Yang YJ, Huang CC, Shih TS, Yang SS. Chronic elemental mercury exposure: clinical and field studies in lamp-socket manufacturers. Occup Environ Med 1994; 51:267-270.
40. Kägi JHR, Schäffer A. Biochemistry of metallothioenin. Biochemistry 1988; 27:8509-8515.
41. Moffatt P, Denizeau F. Metallothioein in physiological and physiopathological processes. Drug Metab Rev 1997; 29:261-307.
42. Sato M, Bremner I. Oxygen free radicals and metallothionein. Free Radical Biol Med 1993; 14:325-337.
43. Uchida Y, Takio K, Titani K, Ihara Y, Tomonaga M. The growth inhibitory factor that is deficient in the Alzeimer's disease brain is a 68 amino acid metallothionein-like protein. Neuron 1991; 7:337-347.
44. Masters BA, Quaife CJ, Erikson JC, Kelly EJ, Froelick GJ, Zambrowicz BP, Brinster RL, Palmiter RD. Metallothionein III is expressed in neurons that sequester zinc in synaptic vesicles. J Neurosci 1994; 14:5844-5857.
45. Zheng H, Berman NEJ, Klaassen CD. Chemical modulation of metallothionein I and III mRNA in mouse brain. Neurochem Int 1995; 27:43-58.
46. Quaife CJ, Findley SD, Erickson JC, Froelick GJ, Kelly EJ, Zambrowicz BP, Palmiter RD. Induction of a new metallothionein isoform (MT-IV) occurs during differentiation of stratified squamous epithelia. Biochemistry 1994; 33:7250-7259.
47. Satoh M, Nishimura N, Kanayama Y, Naganuma A, Suzuki T, Tohyama C. Enchanced renal toxicity by inorganic mercury in metallothionein-null mice. J Pharmacol Exp Ther 1997; 283:1529-1533.
48. Yoshida M, Satoh M, Yasutake A, Shimada A, Sumi Y, Tohyama C. Distribution and retention of mercury in metallothionen-null mice after exposure to mercury vapour. Toxicology 1999; 139:129-136.
49. Zalupas RK, Koropatnick J. Temporal changes in metallothionein gene transcription in rat kidney and liver: relationship to content of mercury and metallothionein protein. J Pharmacol Exp Ther 2000; 295:74-82.
50. Tandon SK, Singh S, Prasad S, Mathur N. Hepatic and renal metallothionein induction by an oral equimolar dose of zinc, cadmium or mercury in mice. Food Chem Toxicol 2001; 39:571-577.
51. 0). Brain Res 1997; 778:222-232.
52. Al-Saleh I, El-Doush I. Mercury content in skin lightening creams and potential hazards to the health of Saudi women. J Toxicol Environ Health 1997; 51:131-148.
53. Food and Drug Administration (FDA). FDA's Cosmetics Handbook. US Department of Health and Human Services, Public Health Service, Food and Drug Administration, 1992.
54. Al-Saleh I, Shinwari N. Urinary mercury levels in females: Influence of skin lightening creams and dental amalgam fillings. BioMetals 1997; 10:315-323.
55. WHO, World Health Organization. Environmental Health Criteria 118: Inorganic mercury, WHO, Geneva, 1991.
56. Rothery E. VGA-76 Vapor Generation Accessory, operating manual. Varian Australia Pty. Ltd., Mulgrave, Victoria, Australia, 1989.
57. Palmer RB, Godwin DA, McKinney PE. Transdermal kinetics of a mercurous chloride beauty cream: an in vitro human skin analysis. J Toxicol-Clin Toxicol 2000; 38:701-707.
58. Friberg L, Skog E, Wahlberg JE. Resorption of mercuric chloride and methyl mercury dicyandiamide in guinea-pigs through normal skin and through skin pre-treated with acetone, alkylary-sulphonate and soap. Acta Dermatovenereol 1961; 41:40-52.
59. 203Hg. J Invest Dermatol 1964; 43:187-192.
60. Wahlberg JE. "Disappearance measurements," a method for studying percutaneous absorption of isotope-labeled compounds emitting gamma-rays. Acta Dermatol Venereol 1965; 45:397-414.
61. 2+ applied to epidermis in mice. Analysis of subcellular fraction. J Dermatol Sci 1995; 10:233-237.
62. Giunta F, Dilandro D, Chiarmda M. Severe acute poisoning from the ingestion of a permanent wave solution of mercuric chloride. Hum Toxicol 1983; 2:243-246.
63. Rosenman KD, Valciukas JA, Glickman L, Meyers BR, Cinotti A. Sensitive indicators of inorganic mercury toxicity. Arch Environ Health 1986; 41:208-215.
64. Enwonwu CO. Potential health hazard of the use of mercury in dentistry: critical review of the literature. Environ Res 1987; 42:257-274.
65. Zalups RK, Barfuss DW. Participation of mercuric conjugates of cystein, homocysteine, and N-acetyl-cysteine in mechanisms involved in the renal tubular uptake of inorganic mercury. J Am Soc Nephrol 1998; 9:551-561.
66. Kuhnert PM, Kuhnert BR, Ehrard P. Comparison of mercury levels in maternal blood, fetal cord blood and placental tissues. Am J Obst Gynecol 1981; 139:209-213.
67. Gale TF. The embryotoxic response produced by inorganic mercury in different strains of hamsters. Environ Res 1981; 24:152-161.
68. Gale TF, Ferm V. Embryopathic effects of mercuric salts. Life Sci 1971; 10:1341-1347.
69. Gale TF, Hanlon DP. The permeability of the Syrian hamster placenta to mercury. Enivron Res 1976; 12:26-31.
70. Holt D, Webb M. The toxicity and teratogenicity of mercury in the pregnant rat. Arch Toxicol 1986; 58:243-248.
71. Duncan-Achanzar KB, Jones JT, Burke MF, Carter DE, Laird DE. Inorganic mecury chloride-induced apoptosis in the cultured porcine renal cell line LLC-PK1. J Pharmacol Exp Ther 1996; 277:1726-1732.
72. Alexidis AN, Rekka E, Kourounakis PN. Effect of mercury on the hepatic microsomal enzymes. Eur J Pharm Sci 1994; 2:170.
73. Strubelt O, Kremer J, Tilse A, Keogh J, Pentz R, Younes M. Comparative studies on the toxicity of mercury, cadmium, and copper toward the isolated perfused rat liver. J Toxicol Environ Health 1996; 47:267-283.
74. Zalups RK, Barfuss DW, Lash LH. Relationships between alterations in glutathione metabolism and the deposition of inorganic mercury in rats: effects of biliary ligation and chemically induced modulation of glutathione status. Chemico-Biological Int 1999; 123:171-195.
75. El-Demerdash FM. Effects of selenium and mercury on the enzymatic activities and lipid peroxidation in brain, liver, and blood of rats. J Environ Sci Health-Part B 2001; 36:489-499.
76. Markovich D, James KM. Heavy metals, mercury, cadmium and chromium inhibit the activity of the mammalian liver and kidney sulfate transporter sat-1. Toxicol Appl Pharmacol 1999; 154:181-187.
77. Eto K, Takizawa Y, Akagi H, Haraguchi K, Asano S, Takahata N, Tokunaga H. Differential diagnosis between organic and inorganic mercury poisoning in human cases. The pathologic point of view. Toxicol Pathol 1999; 27:664-671.
78. Chu CC, Huang CC, Ryu SJ, Wu TN. Chronic inorganic mercury induced peripheral neuropathy. Acta Neurol Scand 1998; 98:461-465.
79. Choi BH, Lapham LW, Amin-Zaki L, Saleem T. Abnormal neuronal migration, deranged cerebral cortical organization, and diffuse white matter astrocytosis of human fetal brain: a major effect of methylmecury poisoning in utero. J Neuropathol Exp Neurol 1978; 37:719-733.
80. Eto K, Takeuchi T. Pathological changes of human sural neves in Minamato disease (methylmercury poisoning). Light and electron microscopic studies. Virchows Archiv B Cell Pathol 1977; 23:109-128.
81. Eto K, Oyanagi S, Itai Y, Tokunaga H, Takizawa Y, Suda I. A fetal type of Minamata disease. An autopsy case report with special reference to the nervous system. Mol Chem Neuropathol 1992; 16:171-186.